Most Read News

HAL announced its first interim dividend of ₹25 per equity share for FY25, totaling a payout of over ₹1,600 crore.

Shilpa Medicare said it has completed Phase 3 trials for SMLNUD07 – Nor Ursodeoxycholic Acid (Nor UDCA) tablets in 165 NAFLD patients in India.

Revenue from operations of the company stood at ₹307.2 crore, with a Year-on-Year (YoY) growth of 39.8% quarter over Q3 FY24 as compared to ₹219.8 crore

EBITDA margin improved to 11.2% vs. 9.7% last year, reflecting better cost management and higher profitability.

On a YoY basis, revenue from operations grew to ₹2,244.9 crore from ₹2,017.2 Cr in Q3 FY24, which translates to an 11.3% increase, indicating steady run-rate business growth

The company stated that its revenue from operations witnessed growth of 34.40% at ₹4,824.80 Crore during the period under review.

So far, the firm had invested about $5 million on pre-development work for a 484 MW wind farm in Mannar and Pooneryn and on the development of Sri Lanka’s 220 KV and 400 KV transmission network.

As part of the collaboration, both companies aim to jointly explore and identify commercial opportunities across different verticals of the BESS value chain.

EBITDA came in at ₹100.1 crore down 9.6% YoY compared to ₹110.7 crore reflecting operating margin pressure.

Ayana Renewable Power is among India’s major renewable energy organizations, primarily focused on large-scale solar and wind projects.